U.S. Court of Appeals for the Federal Circuit
Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
This writing
- Type
- Opinion
- Author
- Alan David Lourie
- Filed
- Sept. 29, 2022
- Case
- Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
- Case status
- Decided
Source The authoring judge was read from the signature line of the court's own published opinion, not from provider metadata — CourtListener records no author for most Sixth Circuit opinions.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 21-2121 Document: 49 Page: 1 Filed: 09/29/2022 United States Court of Appeals for the Federal Circuit ______________________ MYLAN PHARMACEUTICALS INC., Appellant v. MERCK SHARP & DOHME CORP., Appellee ______________________ 2021-2121 ______________________ Appeal from the United States Patent and Tra…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.